Jordan's Hikma Pharmaceuticals has sewn up its deal to buy Bedford Laboratories, a struggling Ohio-based maker of injectable drugs owned by the Boehringer Ingelheim unit Ben Venue Laboratories.
written on 29.05.2014
UPDATED: Hikma snaps up Boehringer sterile injectable assets for up to $300M
